Status:
NOT_YET_RECRUITING
Fecal DNA Methylation and Helicobacter Pylori Gastric Cancer Susceptibility Genes Test
Lead Sponsor:
Fudan University
Conditions:
Gastric (Stomach) Cancer
Eligibility:
All Genders
18+ years
Brief Summary
This is a multicenter, cross-sectional study. It is based on fecal methylation site detection, H. pylori susceptibility testing of fecal samples, and a combination of the two, compared with the "gold ...
Detailed Description
Primary study objective: to evaluate the sensitivity and specificity of fecal methylation site-based and fecal Helicobacter pylori gastric cancer susceptibility gene assays applied to early diagnosis ...
Eligibility Criteria
Inclusion
- Age ≥ 18 years old, male or female not limited.
- Within 90 days, the gastroscopy and/or pathological results confirm the absence of gastric cancer.
- Patients must be able to fully understand the informed consent form and be able to personally sign it.
Exclusion
- Severe cardiac, hepatic, or renal insufficiency, or psychiatric disorders.
- A previous history of malignant tumors of the upper gastrointestinal tract.
- Women during pregnancy.
- Those with undefined pathology.
- Those with unsatisfactory sample retention (e.g., too small a sample size)
Key Trial Info
Start Date :
December 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
9654 Patients enrolled
Trial Details
Trial ID
NCT06943768
Start Date
December 1 2025
End Date
June 30 2026
Last Update
June 24 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.